From mutant mice to "vascular permeability therapy" in cavernous angiomas?
Awad
Issam A
IA
D000818:Animals; D001932:Brain Neoplasms / Q000235:genetics / Q000628:therapy; D002352:Carrier Proteins / Q000235:genetics; D004195:Disease Models, Animal; D006392:Hemangioma, Cavernous / Q000235:genetics / Q000628:therapy; D006801:Humans; D051379:Mice; D008817:Mice, Mutant Strains
C502544:CCM2 protein, human; D002352:Carrier Proteins